ARCHIVES

NCI To Fund 840 Competing Grants In FY 1991; No Downward Negotiations, But Careful Review

This article is from The Cancer Letter archive.

Vol. 16 No. 47 | December 7, 1990

Download PDF Visit The Full Archive

Related Articles

Calcitrol+Docetaxel Prolongs Survival In Prostate Cancer

June 24, 2005

NCI’s Share Of Gramm-Rudman Cuts For FY 1986 Is $54 Million; Staff Ponders How To Absorb It

January 24, 1986

NCCS Begins Program To Help Develop Survivors’ Care Plan

February 27, 2009

In Brief: Columbia-Presbyterian Cancer center to Be Renamed After Donor Herbert Irving

December 6, 1996

ODAC Reviews Post-Marketing Studies for Eight Indications

February 21, 2003

ODAC Okays First “Paper NDA,” By BMS For Bieomycin

October 1, 1993